Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001839298 | SCV002099284 | uncertain significance | Intellectual disability, autosomal dominant 29 | 2021-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002074398 | SCV002463460 | likely benign | not provided | 2024-06-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004529023 | SCV004105235 | uncertain significance | SETBP1-related disorder | 2023-09-25 | criteria provided, single submitter | clinical testing | The SETBP1 c.2741G>A variant is predicted to result in the amino acid substitution p.Arg914Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0054% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-42532046-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004041043 | SCV004946260 | uncertain significance | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | The c.2741G>A (p.R914Q) alteration is located in exon 4 (coding exon 3) of the SETBP1 gene. This alteration results from a G to A substitution at nucleotide position 2741, causing the arginine (R) at amino acid position 914 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |